Congratulations to Paul Richardson, MD, recognized by the Lymphoma, Leukemia, & Myeloma Congress with the Joseph Michaeli Award for Outstanding Contributions to Myeloma. His leadership helped introduce cornerstone treatments for multiple myeloma, each of which has kept the field at the cutting edge.

America's withdrawal from the World Health Organization is affecting the ability of U.S. scientists to track flu and other pathogens. That could be a blow to the development of the 2025 flu vaccine.
www.npr.org/sections/goa...

Annual IMS meeting means back on socials! Dr. Moreau setting the tone with tremendous progress made over the past 3 decades and goals to achieve a cure (we're not far with improvements made in survival outcomes closing in on life expectancy of healthy ppl)!
#IMS25
@myeloma-society.bsky.social

Shonali Midha, MD, discusses how a new program to deliver bispecific T-cell engaging antibodies in the outpatient clinic has successfully reduced hospitalization for patients with multiple myeloma.
https://bit.ly/4igNN5W